|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-8-13
|
|
pubmed:abstractText |
Patients presenting with both arthralgia and antibodies to cyclic citrullinated peptide (anti-CCP) have an increased risk of developing rheumatoid arthritis (RA). To further characterise this patient group and shed more light on its relationship with clinically manifest early arthritis and established RA, an immunogenetic and serological analysis was performed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
pubmed-author:BarteldsG MGM,
pubmed-author:BosW HWH,
pubmed-author:CrusiusJ B AJB,
pubmed-author:DijkmansB A CBA,
pubmed-author:NurmohamedM TMT,
pubmed-author:RaoR LRL,
pubmed-author:UrsumJJ,
pubmed-author:WolbinkG JGJ,
pubmed-author:de VriesNN,
pubmed-author:van SchaardenburgDD,
pubmed-author:van de StadtR JRJ,
pubmed-author:van der Horst-BruinsmaI EIE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1347-50
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18388157-Adult,
pubmed-meshheading:18388157-Aged,
pubmed-meshheading:18388157-Aged, 80 and over,
pubmed-meshheading:18388157-Arthralgia,
pubmed-meshheading:18388157-Arthritis,
pubmed-meshheading:18388157-Arthritis, Rheumatoid,
pubmed-meshheading:18388157-Autoantibodies,
pubmed-meshheading:18388157-Biological Markers,
pubmed-meshheading:18388157-Disease Progression,
pubmed-meshheading:18388157-Epitopes,
pubmed-meshheading:18388157-Female,
pubmed-meshheading:18388157-HLA-DR Antigens,
pubmed-meshheading:18388157-HLA-DRB1 Chains,
pubmed-meshheading:18388157-Humans,
pubmed-meshheading:18388157-Male,
pubmed-meshheading:18388157-Middle Aged,
pubmed-meshheading:18388157-Peptides, Cyclic,
pubmed-meshheading:18388157-Risk Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
|
|
pubmed:affiliation |
Jan van Breemen Institute, Department of Rheumatology, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
